T. Rowe Price Associates’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.4M Sell
103,304
-4,071
-4% -$1.28M ﹤0.01% 846
2025
Q1
$32.7M Sell
107,375
-18,343
-15% -$5.59M ﹤0.01% 834
2024
Q4
$41.8M Sell
125,718
-5,814
-4% -$1.93M ﹤0.01% 806
2024
Q3
$43.9M Sell
131,532
-22,755
-15% -$7.6M 0.01% 792
2024
Q2
$63.5M Sell
154,287
-101,813
-40% -$41.9M 0.01% 645
2024
Q1
$104M Buy
256,100
+3,222
+1% +$1.3M 0.01% 542
2023
Q4
$77.5M Sell
252,878
-13,619
-5% -$4.17M 0.01% 592
2023
Q3
$64.5M Sell
266,497
-58,619
-18% -$14.2M 0.01% 601
2023
Q2
$78.1M Sell
325,116
-1,895
-0.6% -$455K 0.01% 579
2023
Q1
$61.5M Sell
327,011
-14,710
-4% -$2.77M 0.01% 623
2022
Q4
$72.6M Sell
341,721
-17,146
-5% -$3.64M 0.01% 563
2022
Q3
$56.4M Sell
358,867
-30,722
-8% -$4.83M 0.01% 614
2022
Q2
$58.3M Sell
389,589
-88,337
-18% -$13.2M 0.01% 828
2022
Q1
$78.2M Sell
477,926
-15,330
-3% -$2.51M 0.01% 810
2021
Q4
$107M Sell
493,256
-19,973
-4% -$4.35M 0.01% 742
2021
Q3
$97.1M Sell
513,229
-189,782
-27% -$35.9M 0.01% 778
2021
Q2
$124M Sell
703,011
-53,841
-7% -$9.51M 0.01% 708
2021
Q1
$124M Sell
756,852
-24,021
-3% -$3.94M 0.01% 702
2020
Q4
$109M Sell
780,873
-6,425
-0.8% -$894K 0.01% 699
2020
Q3
$88M Buy
787,298
+3,525
+0.4% +$394K 0.01% 693
2020
Q2
$72.9M Buy
783,773
+1,936
+0.2% +$180K 0.01% 724
2020
Q1
$57.4M Buy
781,837
+20,444
+3% +$1.5M 0.01% 737
2019
Q4
$64M Buy
761,393
+19,802
+3% +$1.66M 0.01% 818
2019
Q3
$62.3M Buy
741,591
+162,612
+28% +$13.7M 0.01% 784
2019
Q2
$37.9M Buy
578,979
+283,143
+96% +$18.5M 0.01% 979
2019
Q1
$17.4M Buy
295,836
+290,672
+5,629% +$17.1M ﹤0.01% 1214
2018
Q4
$273K Buy
5,164
+318
+7% +$16.8K ﹤0.01% 2316
2018
Q3
$290K Buy
+4,846
New +$290K ﹤0.01% 2356